A traditional herbal formula, Hyangsa-Pyeongwi san (HPS), improves quality of life (QoL) of the patient with functional dyspepsia (FD): randomized double-blinded controlled trial.

ETHNOPHARMACOLOGICAL RELEVANCE Hyangaa-Pyeongwi san is the most well known description in Traditional Chinese Medicine for treating functional gastrointestinal disorders. Functional dyspepsia (FD) is a main concern of intimidating quality of life (QoL) in recent days. Although many medicines have been developed to improve FD symptoms as well as QoL, there are no potential drugs and treatments for FD. The aim of this study is to investigate the effects of Hyangaa-Pyeongwi san (HPS) on QoL of patients with FD. METHODS This study was designed as a randomized, double blinded, placebo controlled, and parallel group trial. Participants received either placebo or HPS (9.68g of HPS at once, three times daily) for 4-weeks, and the efficacy evaluations were performed by assessing the Nepean Dyspepsia Index (NDI) and functional dyspepsia-quality of life (FD-QoL) at 0-, 4- and 8-weeks. RESULTS Total of 170 patients participated and were randomly allocated into placebo or HPS groups. Total symptom score of NDI decreased after 4-weeks trial in both groups (p>0.05). HPS significantly improved QoL scores, especially in the area of 'interference and eat/drink' in NDI (p=0.0031) as well as 'liveliness status', 'role-functioning status', and total score in FD-QoL (p=0.026 for liveliness status and p=0.035 for role-functioning status). This significant improvement of FD-QoL had lasted for 4-weeks. CONCLUSION HPS treatment is markedly effective in improving QoL in patients with FD. Moreover, we observed that this improvement had lasted for 4 weeks after finishing the trial through the follow-up study.

[1]  M. Camilleri,et al.  Visceral hypersensitivity: facts, speculations, and challenges , 2001, Gut.

[2]  N. Talley,et al.  Minimum Clinically Important Difference for the Nepean Dyspepsia Index, a Validated Quality of Life Scale for Functional Dyspepsia , 2009, The American Journal of Gastroenterology.

[3]  L. Miller,et al.  Dyspepsia, antral motor dysfunction, and gastric stasis of solids , 1980 .

[4]  N. Talley Spectrum of chronic dyspepsia in the presence of the irritable bowel syndrome. , 1991, Scandinavian journal of gastroenterology. Supplement.

[5]  M. Camilleri,et al.  Functional gastroduodenal disorders , 1999, Gut.

[6]  P. Moayyedi,et al.  Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. , 2012, Contemporary clinical trials.

[7]  Pharmacology and Statistics: Recommendations to Strengthen a Productive Partnership , 2006, Pharmacology.

[8]  E. Ernst,et al.  Herbal medicinal products for non‐ulcer dyspepsia , 2002, Alimentary pharmacology & therapeutics.

[9]  H. Mousa,et al.  Improvement of quality of life and symptoms after gastric electrical stimulation in children with functional dyspepsia , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[10]  H. El‐Serag,et al.  The Prevalence and Risk Factors of Functional Dyspepsia in a Multiethnic Population in the United States , 2004, The American Journal of Gastroenterology.

[11]  J. Tack,et al.  Pathophysiology and treatment of functional dyspepsia. , 2005, Journal of clinical gastroenterology.

[12]  G. Holtmann,et al.  A randomized placebo‐controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia , 2002, Alimentary pharmacology & therapeutics.

[13]  O. Markovic,et al.  Anxiety, personality traits and quality of life in functional dyspepsia-suffering patients. , 2013, European journal of internal medicine.

[14]  Talley,et al.  Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies) , 1998, Alimentary pharmacology & therapeutics.

[15]  袁孟彪,et al.  Functional dyspepsia , 2005 .

[16]  Wyeth,et al.  Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index , 1999, Alimentary pharmacology & therapeutics.

[17]  R. Bisschops,et al.  Pathophysiology and treatment of functional dyspepsia. , 2004, Gastroenterology.

[18]  Seong Kook Kim,et al.  Development and validation of a Functional Dyspepsia‐Related Quality of Life (FD‐QOL) scale in South Korea , 2006, Journal of gastroenterology and hepatology.

[19]  N. Talley,et al.  Functional (non‐ulcer) dyspepsia: unexplained but not unmanageable , 1998, The Medical journal of Australia.

[20]  S. Miehlke,et al.  Management of functional dyspepsia: Unsolved problems and new perspectives. , 2005, World journal of gastroenterology.

[21]  G. Holtmann,et al.  Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six‐week placebo‐controlled, double‐blind, multicentre trial , 2003, Alimentary pharmacology & therapeutics.

[22]  B. Burnand,et al.  Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. , 2001 .

[23]  N. Talley Scope of the problem of functional digestive disorders. , 2003, The European journal of surgery. Supplement. : = Acta chirurgica. Supplement.

[24]  P. Enck,et al.  Placebo responses and placebo effects in functional bowel disorders , 2012, European journal of gastroenterology & hepatology.

[25]  Jayachandra,et al.  An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study , 2011, Evidence-based complementary and alternative medicine : eCAM.

[26]  S. Datta,et al.  Study protocol: Couples Partnering for Lipid Enhancing Strategies (CouPLES) – a randomized, controlled trial , 2009, Trials.

[27]  O. Nyrén,et al.  Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. , 1995, Gastroenterology.

[28]  Evidence of a genetic contribution to functional bowel disorder , 1998 .

[29]  N. Talley,et al.  Non‐ulcer dyspepsia: myths and realities , 1991, Alimentary pharmacology & therapeutics.

[30]  P. Enck,et al.  Placebo responses in patients with gastrointestinal disorders. , 2007, World journal of gastroenterology.

[31]  Yong Tang,et al.  Acupuncture as a treatment for functional dyspepsia: design and methods of a randomized controlled trial , 2009, Trials.